| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44027303 | HTLV-1 | ENSG00000140675.13 | protein_coding | SLC5A2 | No | No | 6524 | P31639 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | SLC5A2 |
|---|---|
| DrugBank ID | DB11827 |
| Drug Name | Ertugliflozin |
| Target ID | BE0004753 |
| UniProt ID | P31639 |
| Regulation Type | inhibitor |
| PubMed IDs | 23169609 |
| Citations | Miao Z, Nucci G, Amin N, Sharma R, Mascitti V, Tugnait M, Vaz AD, Callegari E, Kalgutkar AS: Pharmacokinetics, metabolism, and excretion of the antidiabetic agent ertugliflozin (PF-04971729) in healthy male subjects. Drug Metab Dispos. 2013 Feb;41(2):445-56. doi: 10.1124/dmd.112.049551. Epub 2012 Nov 20. |
| Groups | Approved; Investigational |
| Direct Classification | Diphenylmethanes |
| SMILES | CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@]23OC[C@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)C=C1 |
| Pathways | |
| PharmGKB | PA166269521 |
| ChEMBL | CHEMBL1770248 |
